Gagnon Securities’s Redhill Biopharma RDHL Stock Holding History
Bought
Maintained
Sold
Other funds holding RDHL
YAG
XT
SG
TSS
GI
FDCDDQ
YAL
Gagnon Securities's RDHL Position: Q1 2026 in Review
Gagnon Securities increased its Redhill Biopharma (RDHL) stake by 2.7% in Q1 2026, buying an estimated $2.43K and bringing the position to 88,405 shares worth $65.9K. The position accounts for 0.02% of the portfolio, ranked #85.
Gagnon Securities first reported a position in RDHL in Q4 2019 and has held it in 20 quarters since. The position peaked at $2.43M in Q3 2020. 16 funds tracked by Wall St. Rank hold RDHL as of Q1 2026.
- Gagnon Securities held 88,405 shares of Redhill Biopharma worth $65.9K as of Q1 2026.
- Gagnon Securities bought 2,303 Redhill Biopharma shares in Q1 2026, an estimated $2.43K.
- Redhill Biopharma made up 0.02% of Gagnon Securities's portfolio in Q1 2026, its #85 holding.
- Gagnon Securities first reported a position in Redhill Biopharma in Q4 2019 and has held it in 20 quarters since.
- Gagnon Securities's Redhill Biopharma position peaked at $2.43M in Q3 2020.
- 16 funds tracked by Wall St. Rank held Redhill Biopharma as of Q1 2026.
Based on Gagnon Securities's 13F filing for Q1 2026, filed 22 Apr 2026.